These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
448 related articles for article (PubMed ID: 16527697)
21. High lifetime risk of cancer in primary sclerosing cholangitis. Claessen MM; Vleggaar FP; Tytgat KM; Siersema PD; van Buuren HR J Hepatol; 2009 Jan; 50(1):158-64. PubMed ID: 19012991 [TBL] [Abstract][Full Text] [Related]
22. Colorectal neoplasia in Crohn's colitis: a retrospective comparative study with ulcerative colitis. Svrcek M; Cosnes J; Beaugerie L; Parc R; Bennis M; Tiret E; Fléjou JF Histopathology; 2007 Apr; 50(5):574-83. PubMed ID: 17394493 [TBL] [Abstract][Full Text] [Related]
23. Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease. Romberg-Camps MJ; Dagnelie PC; Kester AD; Hesselink-van de Kruijs MA; Cilissen M; Engels LG; Van Deursen C; Hameeteman WH; Wolters FL; Russel MG; Stockbrügger RW Am J Gastroenterol; 2009 Feb; 104(2):371-83. PubMed ID: 19174787 [TBL] [Abstract][Full Text] [Related]
24. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Minnesota. Jess T; Loftus EV; Velayos FS; Harmsen WS; Zinsmeister AR; Smyrk TC; Schleck CD; Tremaine WJ; Melton LJ; Munkholm P; Sandborn WJ Gastroenterology; 2006 Apr; 130(4):1039-46. PubMed ID: 16618397 [TBL] [Abstract][Full Text] [Related]
25. Ursodeoxycholic acid treatment in IBD-patients with colorectal dysplasia and/or DNA-aneuploidy: a prospective, double-blind, randomized controlled pilot study. Sjöqvist U; Tribukait B; Ost A; Einarsson C; Oxelmark L; Löfberg R Anticancer Res; 2004; 24(5B):3121-7. PubMed ID: 15510599 [TBL] [Abstract][Full Text] [Related]
26. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study. Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B; Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104 [TBL] [Abstract][Full Text] [Related]
27. Risk of arterial thrombotic events in inflammatory bowel disease. Ha C; Magowan S; Accortt NA; Chen J; Stone CD Am J Gastroenterol; 2009 Jun; 104(6):1445-51. PubMed ID: 19491858 [TBL] [Abstract][Full Text] [Related]
28. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years. Jess T; Simonsen J; Jørgensen KT; Pedersen BV; Nielsen NM; Frisch M Gastroenterology; 2012 Aug; 143(2):375-81.e1; quiz e13-4. PubMed ID: 22522090 [TBL] [Abstract][Full Text] [Related]
29. Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members. Watson P; Lin KM; Rodriguez-Bigas MA; Smyrk T; Lemon S; Shashidharan M; Franklin B; Karr B; Thorson A; Lynch HT Cancer; 1998 Jul; 83(2):259-66. PubMed ID: 9669808 [TBL] [Abstract][Full Text] [Related]
30. Cancer and pediatric inflammatory bowel disease. Kayton ML Semin Pediatr Surg; 2007 Aug; 16(3):205-13. PubMed ID: 17602977 [TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus infection in colorectal neoplasms associated with inflammatory bowel disease: detection of the virus in lymphomas but not in adenocarcinomas. Wong NA; Herbst H; Herrmann K; Kirchner T; Krajewski AS; Moorghen M; Niedobitek F; Rooney N; Shepherd NA; Niedobitek G J Pathol; 2003 Oct; 201(2):312-8. PubMed ID: 14517849 [TBL] [Abstract][Full Text] [Related]
32. Malignancy in Crohn's disease: incidence and clinical characteristics in Japan. Mizushima T; Ohno Y; Nakajima K; Kai Y; Iijima H; Sekimoto M; Nishida T; Nezu R; Ito T; Doki Y; Mori M Digestion; 2010; 81(4):265-70. PubMed ID: 20134166 [TBL] [Abstract][Full Text] [Related]
34. The incidence of inflammatory bowel disease in a rural region of Southern Germany: a prospective population-based study. Ott C; Obermeier F; Thieler S; Kemptner D; Bauer A; Schölmerich J; Rogler G; Timmer A Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):917-23. PubMed ID: 18794607 [TBL] [Abstract][Full Text] [Related]
35. Distinct clinicohistologic features of inflammatory bowel disease-associated colorectal adenocarcinoma: in comparison with sporadic microsatellite-stable and Lynch syndrome-related colorectal adenocarcinoma. Liu X; Goldblum JR; Zhao Z; Landau M; Heald B; Pai R; Lin J Am J Surg Pathol; 2012 Aug; 36(8):1228-33. PubMed ID: 22790862 [TBL] [Abstract][Full Text] [Related]
36. Impact of Clostridium difficile on inflammatory bowel disease. Issa M; Vijayapal A; Graham MB; Beaulieu DB; Otterson MF; Lundeen S; Skaros S; Weber LR; Komorowski RA; Knox JF; Emmons J; Bajaj JS; Binion DG Clin Gastroenterol Hepatol; 2007 Mar; 5(3):345-51. PubMed ID: 17368234 [TBL] [Abstract][Full Text] [Related]
37. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database. Vind I; Riis L; Jess T; Knudsen E; Pedersen N; Elkjaer M; Bak Andersen I; Wewer V; Nørregaard P; Moesgaard F; Bendtsen F; Munkholm P; Am J Gastroenterol; 2006 Jun; 101(6):1274-82. PubMed ID: 16771949 [TBL] [Abstract][Full Text] [Related]
38. Psychological stress and inflammatory bowel disease: a follow-up study in parents who lost a child in Denmark. Li J; Nørgard B; Precht DH; Olsen J Am J Gastroenterol; 2004 Jun; 99(6):1129-33. PubMed ID: 15180736 [TBL] [Abstract][Full Text] [Related]
39. Abnormal p53 immunohistochemistry is associated with an increased colorectal cancer-related mortality in patients with ulcerative colitis. Lashner BA; Bauer WM; Rybicki LA; Goldblum JR Am J Gastroenterol; 2003 Jun; 98(6):1423-7. PubMed ID: 12818291 [TBL] [Abstract][Full Text] [Related]
40. Are patients with inflammatory bowel disease receiving optimal care? Reddy SI; Friedman S; Telford JJ; Strate L; Ookubo R; Banks PA Am J Gastroenterol; 2005 Jun; 100(6):1357-61. PubMed ID: 15929770 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]